Transcription of DRUG NAME: Mitomycin
{{id}} {{{paragraph}}}
Example: barber
DRUG NAME: Mitomycin
Mitomycin DRUG NAME: Mitomycin SYNONYM(S): Mitomycin C,1 MMC1. COMMON TRADE NAME(S): MUTAMYCIN . CLASSIFICATION: antitumour antibiotic Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: 2. Mitomycin is derived from Streptomyces caespitosus and has antineoplastic activity similar to that of the alkylating 3 2,3. agents. Mitomycin selectively inhibits the synthesis of DNA by causing cross-linking, degrades preformed DNA, 4. and causes nuclear lysis and formation of giant cells.
vincristine have been beneficial in some patients. 1: Mitomycin BC Cancer Drug Manual ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology
Related documents
LEARNING FROM ERROR - WHO
www.who.intVincristine: what went wrong? Vincristine, a widely used chemotherapeutic agent, should only be administered intravenously and never by any other route. Many patients receiving intravenous vincristine also receive other medication via a spinal route as part of their treatment protocol. This has led to errors where vincristine has
PRESERVATIVE FREE SOLUTION
www.accessdata.fda.govVincristine Sulfate, USP is a white to off–white powder. It is soluble in methanol, freely soluble in water, but only slightly soluble in 95% ethanol. In 98% ethanol, Vincristine Sulfate, USP has an ultraviolet . Vincristine Sulfate Injection, USP is a sterile, preservative–free, single use only solution available for
NSSG Chemotherapy Protocol
nssg.oxford-haematology.org.ukINPATIENT regimen (Etoposide/ Doxorubicin/ Vincristine ) ETOPOSIDE IV infusion in 500 mL sodium chloride 0.9% over 24 hours. Replace bag promptly daily for a continuous infusion over 96 hours. DOXORUBICIN and VINCRISTINE are mixed together, made up to 48 mL with sodium chloride 0.9% IV infusion and administered via a LV infusor over 96 hours.
(*riTUXimab) Cyclophosphamide, DOXOrubicin, vinCRIStine ...
www.hse.ieConsider vinCRIStine dose reduction in elderly patients. Haematological: Table 2: Dose modification in haematological toxicity ANC (x10 9 /L) Platelets (x10 9 /L) Dose < 1 and/or < 75 Delay treatment until recovery. Consider treatment delay and/or adding G-CSF. Renal and Hepatic Impairment:
2020-2021 ISMP Targeted Medication Safety Best Practices ...
www.ismp.orgDispense vinCRIStine and other vinca alkaloids in a minibag of a compatible solution and not in a syringe. Rationale: The goal of this Best Practice is to ensure that vinca alkaloids are only administered by the intravenous route. Vinca alkaloids (vinBLAStine, vinorelbine, vinCRIStine,
R-CHOP-21 / CHOP-21 - NSSG - Haematology
nssg.oxford-haematology.org.uk* Vincristine 1 mg in patients over 70 years of age. Pretreatment with steroids: Some older patients may benefit from a steroid pre-phase consisting of 7 days of oral prednisolone at a dose of 50-100 mg daily. G-CSF primary prophylaxis: Consider for all patients from day 6 for 5 or 7 days. CYCLE FREQUENCY Cycle repeats every 21 days. RESTAGING
PRINCIPLES OF CHEMOTHERAPY IN CANCER
oncologypro.esmo.orgVincristine Vinblastine Vinorelbine Mechanism of action: Bind to microtubular proteins, thus inhibit microtubule assembly resulting in dissolution of the mitotic assembly structure. M- phase specific drugs. Eribulin (Non-taxane tubulin binding agent A marine sponge product)
BC Cancer Protocol Summary for Treatment of Lymphoma …
www.bccancer.bc.caBC Cancer Protocol Summary LYCHOPR Page 1 of 5 Activated: 5 Mar 2001 Revised: 1 June 2021 (IV bag size clarified) Warning: The information contained in these documents are a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment.
University of Wisconsin – Madison Lymphoma CHOP-19 …
uwveterinarycare.wisc.eduIf in complete remission at week 19, all therapy stops and monthly re-evaluations are instituted. Total Doxorubicin dose to date: ______ mg _______ mg/m 2